ABBREVIATIONSEID(s)emerging infectious disease(s)PRpathogen reductionBlood as well as blood products are used as part of supporting medical strategies for saving lives. However, qualified donations are not as safe as previously supposed. Except for routinely tested pathogens such as human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis, a large number of infectious agents exist in qualified blood, which can impact blood safety and might turn into transfusion‐transmitted diseases. However, there has been no investigation of the diverse pathogens in pooled plasma from manufacturers to date in China for evaluating the blood safety issue caused by undetected pathogens.Hence, we initiated this study to investigate emerging infectious diseases (EIDs) in pooled plasma from manufacturers in Chengdu and Guiyang, China. Random polymerase chain reaction (PCR) and homology testing were used to determine the microbes in the pooled plasma, and the infection status of EIDs that might jeopardize blood safety was then identified.MATERIALS AND METHODSMaterials collection and treatmentEach 12 mL of pooled plasma (8000 donations) from two manufacturers located in Chengdu, Sichuan Province, and Guiyang, Guizhou Province, China, was collected. The samples were first filtered through a 0.45‐μm‐disk filter and second filtered through a 0.22‐μm‐disk filter (Millex GV). The filtered samples were then ultracentrifuged
Transfusion – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera